Article
Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.
Genes and immunity - 1 Jun 2009
Yee L J, Im K, Borg B, Yang H, Liang T J
Abstract excerpt
Chronic hepatitis C virus (HCV) infection affects nearly 170 million individuals worldwide. Treatment of HCV with pegylated interferon-alpha-2a is successful in eradicating virus from only 30 to 80% of those treated. Interleukin-6 (IL-6) is an important cytokine involved in the immune response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
